DOPAMINE RECEPTOR CHARACTERIZATION - AGONIST REQUIREMENTS FOR BINDING USING [H-3]-6,7,-DIHYDROXY 1,2,3,4-TETRAHYDRONAPTHALENE (ADTN) - POTENTIAL SPECIFIC DOPAMINE RECEPTOR LIGAND

被引：0
|
作者：
ABEL, MS
CLEMENTCORMIER, Y
机构：
[1] UNIV TEXAS,DEPT PHARM,HOUSTON,TX 77030
[2] UNIV TEXAS,DEPT NEUROBIOL,HOUSTON,TX 77030
来源：
PHARMACOLOGIST | 1978年 / 20卷 / 03期
关键词：
D O I：
暂无
中图分类号：
R9 [药学];
学科分类号：
1007 ;
摘要：
引用
收藏
页码：241 / 241
页数：1
相关论文
共 50 条
  • [1] [H-3] 2-AMINO-6,7-DIHYDROXY 1,2,3,4-TETRAHYDRONAPTHALENE (ADTN) - POTENTIAL SPECIFIC DOPAMINE RECEPTOR LIGAND
    CLEMENTCORMIER, Y
    ABEL, M
    RESEARCH COMMUNICATIONS IN CHEMICAL PATHOLOGY AND PHARMACOLOGY, 1978, 22 (01): : 15 - 25
  • [2] DOPAMINE RECEPTOR-BINDING OF ADTN-H-3 (2-AMINO-6,7-DIHYDROXY-1,2,3,4-TETRAHYDRONAPHTHALENE) REGULATED BY GUANYL NUCLEOTIDES
    CREESE, I
    SNYDER, SH
    EUROPEAN JOURNAL OF PHARMACOLOGY, 1978, 50 (04) : 459 - 461
  • [3] COMPARISON OF EFFECTS OF 2-AMINO-6,7-DIHYDROXY-1,2,3,4-TETRAHYDRONAPTHALENE(ADTN) AND APOMORPHINE(APO) ON DOPAMINE-SENSITIVE CILIARY ACTIVITY AND CAMP LEVELS IN BIVALVE MOLLUSCAN GILL
    MALANGA, CJ
    ODONNELL, JP
    POLL, KA
    PHARMACOLOGIST, 1977, 19 (02): : 204 - 204
  • [4] C(2)-METHYLATION ABOLISHES DA1 DOPAMINE AGONIST ACTIVITY OF 2-AMINO-6,7-DIHYDROXY-1,2,3,4-TETRAHYDRONAPHTHALENE (6,7-ADTN) - STERIC INTOLERANCE BY THE RECEPTOR
    NICHOLS, DE
    JACOB, JN
    HOFFMAN, AJ
    KOHLI, JD
    GLOCK, D
    JOURNAL OF MEDICINAL CHEMISTRY, 1984, 27 (12) : 1701 - 1705
  • [5] USE OF ADTN(2-AMINO-6,7-DIHYDROXY-1,2,3,4-TETRAHYDRONAPHTHALENE) AS A LIGAND FOR BRAIN DOPAMINE RECEPTORS
    CROSS, AJ
    CROW, TJ
    OWEN, F
    BRITISH JOURNAL OF PHARMACOLOGY, 1979, 66 (01) : P87 - P88
  • [6] DOPAMINE-D2 RECEPTOR-BINDING PROPERTIES OF [H-3] U-86170, A DOPAMINE RECEPTOR AGONIST
    LAHTI, RA
    EVANS, DL
    FIGUR, LM
    CARRIGAN, KJ
    MOON, MW
    HSI, RS
    EUROPEAN JOURNAL OF PHARMACOLOGY, 1991, 202 (02) : 289 - 291
  • [7] CHARACTERIZATION OF BINDING OF [H-3]PD-128907, A SELECTIVE DOPAMINE D-3 RECEPTOR AGONIST LIGAND, TO CHO-K1 CELLS
    AKUNNE, HC
    TOWERS, P
    ELLIS, GJ
    DIJKSTRA, D
    WIKSTROM, H
    HEFFNER, TG
    WISE, LD
    PUGSLEY, TA
    LIFE SCIENCES, 1995, 57 (15) : 1401 - 1410
  • [8] MULTIPLE DAILY AMPHETAMINE ADMINISTRATION DECREASES BOTH [H-3] AGONIST AND [H-3] ANTAGONIST DOPAMINE RECEPTOR-BINDING
    SIBLEY, DR
    WEINBERGER, S
    SEGAL, DS
    CREESE, I
    EXPERIENTIA, 1982, 38 (10): : 1224 - 1225
  • [9] DOPAMINE (D2) AGONIST RECEPTOR-BINDING PROPERTIES OF [H-3] U-86170
    LAHTI, RA
    HSI, RS
    MOON, MW
    HUFF, RM
    PIERCEY, MF
    FIGUR, LM
    EVANS, DL
    SCHIZOPHRENIA RESEARCH, 1991, 4 (03) : 319 - 320
  • [10] DOPAMINE-D2 RECEPTOR-BINDING IN ADRENAL-MEDULLA - CHARACTERIZATION USING [H-3] SPIPERONE
    QUIK, M
    BERGERON, L
    MOUNT, H
    PHILIE, J
    BIOCHEMICAL PHARMACOLOGY, 1987, 36 (21) : 3707 - 3713
12345